MetroNIDAZOLE 0.75 % Vaginal Gel
RxNorm 142046
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 142046 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: metroNIDAZOLE 0.75 % Vaginal Gel.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Metronidazole 0.0075 mg/MG Vaginal Gel
(Atom ID: 12336254)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 0.0075 mg/MG Vaginal Gel
(Atom ID: 3728397)
PSNPrescribable
Prescribable Name (PSN):
MetroNIDAZOLE 0.75 % Vaginal Gel
(Atom ID: 6393964)
SYPrescribable
Synonym (SY):
Metronidazole 0.75 % Vaginal Gel
(Atom ID: 2980902)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
MetroNIDAZOLE 0.75 % Vaginal Gel
(Atom ID: 3724846)
PTPrescribable
Designated preferred name (PT):
Metronidazole 7.5 mg/g vaginal gel
(Atom ID: 10301715)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely metronidazole 7.5 mg/1 gram conventional release vaginal gel (clinical drug)
(Atom ID: 10314915)
Patient Education
Metronidazole Vaginal
Metronidazole is used to treat vaginal infections such as bacterial vaginosis (an infection caused from too much of certain bacteria in the vagina). Metronidazole is in a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria.
[Learn More]
* Please review the disclaimer below.